Exploring safe and potent bioactives for the treatment of non-small cell lung cancer
- 26 April 2021
- journal article
- research article
- Published by Springer Nature in 3 Biotech
- Vol. 11 (5) , 1-11
Abstract
Activating and suppressing mutations in the MAPK pathway receptors are the primary causes of NSCLC. Of note, MEK inhibition is considered a promising strategy because of the diverse structures and harmful effects of upstream receptors in MAPK pathway. Thus, we explore a total of 1574 plant-based bioactive compounds activity against MEK using an energy-based virtual screening strategy. Molecular docking, binding free energy, and drug-likeness analysis were performed through GLIDE, Prime MM-GBSA, and QikProp module, respectively. The findings indicate that 5-O-caffeoylshikimic acid has an increased binding affinity to MEK protein. Further, molecular dynamic simulations and MM-PBSA analysis were performed to explore the ligand activity in real-life situations. In essence, compounds inhibitory activity was validated across 77 lung cancer cell lines using multimodal attention-based neural network algorithm. Eventually, our analysis highlight that 5-O-caffeoylshikimic acid obtained from the bark of Rhizoma smilacis glabrae would be developed as a potential compound for treating NSCLC.Keywords
This publication has 52 references indexed in Scilit:
- Simple Estimation of Förster Resonance Energy Transfer (FRET) Orientation Factor Distribution in MembranesInternational Journal of Molecular Sciences, 2012
- Drug Solubility: Importance and Enhancement TechniquesISRN Pharmaceutics, 2012
- Molecular dynamics simulations and drug discoveryBMC Biology, 2011
- Molecular docking for virtual screening of natural product databasesChemical Science, 2011
- Accounting for water molecules in drug designExpert Opinion on Drug Discovery, 2010
- Energetic domains analysis of bovine α-lactalbumin upon interaction with copper and dodecyl trimethylammonium bromideJournal of Molecular Structure, 2010
- Solvent accessible surface area approximations for rapid and accurate protein structure predictionJournal of Molecular Modeling, 2009
- Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screeningMolecular Cancer Therapeutics, 2008
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- Identification of a Novel Mitogen-Activated Protein Kinase Kinase Activation Domain Recognized by the Inhibitor PD 184352Molecular and Cellular Biology, 2002